Stephen Doberstein Net Worth & Insider Trades

Stephen Doberstein - SVP & Chief Scientific Officer, Nektar Therapeutics

As of September 9, 2019

What is Stephen Doberstein's Net Worth?

The current estimated net worth of Nektar Therapeutics's SVP & Chief Scientific Officer, Stephen Doberstein, is estimated to be about $30.87M . Stephen Doberstein owns about 107,668 units of Nektar Therapeutics common stock. In the last 9 years at Nektar Therapeutics, Stephen Doberstein has sold an estimated value of $31.34M worth.

What is Stephen Doberstein's Past Insider Trading?

Stephen Doberstein's largest purchase order was 396,323 units , worth over $3.78M on November 8, 2017. Stephen Doberstein's largest sale order was 160,000 units , worth over $14.89M on April 9, 2018. In total, Stephen Doberstein has made about 31 transactions over 9 years of their time at Nektar Therapeutics. Stephen Doberstein usually trades in February, with the busiest year in 2017. The most recent transaction was a purchase order of 15,000 units , worth over $259.2K on September 9, 2019.

Stephen Doberstein

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Stephen Doberstein's' Mailing Address?

  • Mailing address is 129 Elsie Street San Francisco CA 94110 CA

What are Nektar Therapeutics's Past Insider Trades?

Nektar Therapeutics's most recent insider trade came on May 17, 2023 by Jonathan Zalevsky who sold 9,791 units worth $7.05K . In the last 20 years, insiders at Nektar Therapeutics have sold an estimated value of $295.31M and bought an estimated value of $84.98M worth of shares. Insider trading is most common in September, with the busiest year in 2016 and 2017. The most active traders at the company are Howard Robin, President & CEO,  Gil Labrucherie, SVP,  and Robert Chess, Director .

NEKTAR THERAPEUTICS Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...